Cognitive function in multiple sclerosis and its modulation by cholinergic drugs

Cognitive function in multiple sclerosis and its modulation by cholinergic drugs

<p>In order to assess cognitive function in multiple sclerosis (MS) and the effect of cholinergic modulation, experiments were conducted using functional magnetic resonance imaging (fMRI) to assess the brain activation during cognitive tasks.</p> <p>A study comparing the processin...

Bibliografske podrobnosti
Main Authors:	Cader, S, Cader, Sarah
Drugi avtorji:	Matthews, P
Format:	Thesis
Jezik:	English
Izdano:	2005
Teme:	Treatment Effect of drugs on Multiple sclerosis Brain Cholinergic mechanisms

Podobne knjige/članki

Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis
od: Valentina Gatta, et al.
Izdano: (2020-06-01)

Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis
od: A. N. Boyko, et al.
Izdano: (2019-12-01)

Adherence to Anticholinergic Therapy and Clean Intermittent Self-Catheterization in Patients With Multiple Sclerosis
od: Damien Motavasseli, et al.
Izdano: (2018-06-01)

Exploring the vertebrate cholinergic nervous system /
od: Karczmar, A. G. (Alexander George), 1918-, et al.
Izdano: (2007)

Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
od: Esther Melamed, et al.
Izdano: (2020-01-01)

Brain Stimulation for Cognitive impairment in Multiple Sclerosis (ORP-17)
od: Mehrdad Roozbeh
Izdano: (2023-01-01)

Axonal injury and its mechanisms in multiple sclerosis
od: Xue⁃qiang HU, et al.
Izdano: (2012-04-01)

Comparison Effect of Prescription Drugs on the Occurrence and the Number of Attacks in Patients with Multiple Sclerosis
od: Marjan Jamalian, et al.
Izdano: (2018-01-01)

Role of Cholinergic Signaling in Alzheimer’s Disease
od: Zhi-Ru Chen, et al.
Izdano: (2022-03-01)

Effects of disease-modifying drugs in multiple sclerosis on the gut microbiome
od: Мadina А. Omarova, et al.
Izdano: (2024-01-01)

Multiple Sclerosis and Microbiome
od: Jana Lizrova Preiningerova, et al.
Izdano: (2022-03-01)

Physiotherapy in multiple sclerosis
od: Anna Łuszczyńska, et al.
Izdano: (2015-10-01)

Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region
od: V. B. Laskov, et al.
Izdano: (2017-03-01)

Non-neuronal cholinergic system in the heart influences its homeostasis and an extra-cardiac site, the blood-brain barrier
od: Yoshihiko Kakinuma
Izdano: (2024-03-01)

Multiple sclerosis /
od: 546326 Dobson, Ruth, et al.
Izdano: (2013)

Non-Pharmacological Treatments of Cognitive Impairment in Multiple Sclerosis: A Review
od: Michela Bossa, et al.
Izdano: (2022-08-01)

Adherence to disease-modifying therapies in patients with multiple sclerosis
od: Kołtuniuk A, et al.
Izdano: (2018-08-01)

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets
od: N. A. Totolyan, et al.
Izdano: (2020-10-01)

Uveitis Related with Multiple Sclerosis
od: Sirel Gür Güngör, et al.
Izdano: (2012-12-01)

Brain atrophy: an in-vivomeasure of disease activity in multiple sclerosis
od: Ernst Wilhelm Radü, et al.
Izdano: (2013-11-01)

Early and severe cognitive impairment in multiple sclerosis
od: Maria Fernanda Mendes, et al.

Optimization of therapy in secondary progressive multiple sclerosis
od: A. N. Boyko, et al.
Izdano: (2024-08-01)

Multiple Sclerosis: Methods of Treatment and Rehabilitation
od: Yuriy Lysenko
Izdano: (2017-06-01)

Improving Visual Working Memory with Cholinergic Deep Brain Stimulation
od: Janki M. Bava, et al.
Izdano: (2023-06-01)

Simulation of Cholinergic and Noradrenergic Modulation of Behavior in Uncertain Environments
od: Michael C Avery, et al.
Izdano: (2012-01-01)

Multiple sclerosis : recovery of function and neurorehabilitation /
od: Kesselring, Jurg, et al.
Izdano: (c201)

Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities
od: Eric H. Chang, et al.
Izdano: (2019-04-01)

General Principles of Treatment of Multiple Sclerosis in Children
od: Shorobura M.
Izdano: (2014-12-01)

Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.
od: Cader, S, et al.
Izdano: (2009)

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey
od: Christian P. Kamm, et al.
Izdano: (2018-10-01)

A review of treatment of relapsing-remitting type of multiple sclerosis (RRMS)
od: Arkadiusz Bydliński, et al.
Izdano: (2024-05-01)

Gut flora in multiple sclerosis: implications for pathogenesis and treatment
od: Weiwei Zhang, et al.
Izdano: (2024-01-01)

Evaluation of association between flu-like syndrome induced by Beta Interferon drug and required drug response in patients with Multiple sclerosis
od: Abdollah Ghaferi, et al.
Izdano: (2019-08-01)

Are highly active and aggressive multiple sclerosis the same entity?
od: Jorge Correale, et al.
Izdano: (2023-03-01)

Cognitive dysfunction in Multiple Sclerosis
od: Joana eGuimarães, et al.
Izdano: (2012-05-01)

A case report of Cholinergic syndrome an unusual complication of Neostigmine administration
od: Z Hussain Khan, et al.
Izdano: (2002-07-01)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
od: Ruth Ann Marrie, et al.
Izdano: (2022-04-01)

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
od: Weipeng Wei, et al.
Izdano: (2021-07-01)

System biology review of multiple sclerosis and discovery of drug targets (ORP-54)
od: Ali Alizadeh Amiri
Izdano: (2023-01-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
od: T. I. Yakushina
Izdano: (2021-02-01)